Si Creva Capital Services & Temasek Holdings

Si Creva Capital Services: Si Creva Capital Services is a book-running lead manager for the IPO, earning fees and enhancing its reputation.

Temasek Holdings: Temasek Holdings, through its subsidiary V Sciences Investments, is a significant investor in Molbio Diagnostics. The IPO provides an opportunity for partial exit and is likely to generate positive returns on its investment.

Si Creva Capital Services: As a book-running lead manager, Si Creva Capital Services played a role in the IPO's execution, benefiting from the strong demand.

Temasek Holdings: Through its subsidiary, Temasek invested ₹482 crore pre-IPO, gaining from the strong listing and demonstrating confidence in the Indian dairy sector.

Si Creva Capital Services: IIFL Capital, as a lead manager, gains from the IPO's execution, enhancing its investment banking credentials.

Temasek Holdings: Temasek, through its subsidiary Jongsong Investments, invested Rs 482 crore in a pre-IPO placement, gaining exposure to the Indian dairy market. This investment is expected to yield returns if the IPO performs well.

Si Creva Capital Services: Recommended the IPO as a long-term investment opportunity.

Temasek Holdings: Temasek is a backer of Manipal Health Enterprises, supporting the IPO as an existing investor.

Si Creva Capital Services: Si Creva Capital Services is one of the managers for the CleanMax IPO.

Si Creva Capital Services: Si Creva Capital Services was appointed as a book-running lead manager for Milky Mist Dairy Food's proposed IPO.